# International Business Machines Corp: overview

IBM · NYSE · CIK 51143 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ibm.md) · [Financials](/companies/ibm/financials.md) · [Filings](/companies/ibm/filings.md) · [Insiders](/companies/ibm/insiders.md)

Latest reported revenue: [$17.10bn](/filings/0000051143-26-000095.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 22, 2026 (XBRL us-gaap:Revenues, accession 0000051143-26-000095).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [17.6 d](/filings/0000051143-26-000010.md) | [14.5](/filings/0000051143-26-000038.md) | [17.0](/filings/0000051143-26-000078.md) | [16.3](/filings/0000051143-26-000095.md) | [19.7 d](/filings/0000051143-26-000010.md) | [15.9](/filings/0000051143-26-000038.md) | [17.2](/filings/0000051143-26-000078.md) | [17.1](/filings/0000051143-26-000095.md) |
| Gross margin | % | [59.5% d](/filings/0000051143-26-000010.md) | [55.2%](/filings/0000051143-26-000038.md) | [58.8%](/filings/0000051143-26-000078.md) | [57.3%](/filings/0000051143-26-000095.md) | [60.6% d](/filings/0000051143-26-000010.md) | [56.2%](/filings/0000051143-26-000038.md) | [57.7%](/filings/0000051143-26-000078.md) | [56.8%](/filings/0000051143-26-000095.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [16.6% d](/filings/0000051143-26-000010.md) | [7.3%](/filings/0000051143-26-000038.md) | [12.9%](/filings/0000051143-26-000078.md) | [10.7%](/filings/0000051143-26-000095.md) | [28.4% d](/filings/0000051143-26-000010.md) | [7.6%](/filings/0000051143-26-000038.md) | [12.6%](/filings/0000051143-26-000078.md) | [12.8%](/filings/0000051143-26-000095.md) |
| Diluted EPS | $ per share | not reported | [1.12](/filings/0000051143-26-000038.md) | [2.31](/filings/0000051143-26-000078.md) | [1.84](/filings/0000051143-26-000095.md) | not reported | [1.28](/filings/0000051143-26-000038.md) | [2.27](/filings/0000051143-26-000078.md) | [2.30](/filings/0000051143-26-000095.md) |
| Free cash flow | $bn | [4.0 d](/filings/0000051143-26-000010.md) | [4.1](/filings/0000051143-26-000038.md) | [1.5 d](/filings/0000051143-26-000078.md) | [2.8 d](/filings/0000051143-26-000095.md) | [3.7 d](/filings/0000051143-26-000010.md) | [4.9](/filings/0000051143-26-000038.md) | [2.4 d](/filings/0000051143-26-000078.md) | [3.7 d](/filings/0000051143-26-000095.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [57.4](/filings/0000051143-24-000012.md) | [60.5](/filings/0000051143-25-000015.md) | [61.9](/filings/0000051143-26-000010.md) | [62.8](/filings/0000051143-26-000010.md) | [67.5](/filings/0000051143-26-000010.md) |
| Gross margin | % | [54.9%](/filings/0000051143-24-000012.md) | [54.0%](/filings/0000051143-25-000015.md) | [55.4%](/filings/0000051143-26-000010.md) | [56.7%](/filings/0000051143-26-000010.md) | [58.2%](/filings/0000051143-26-000010.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [10.0%](/filings/0000051143-24-000012.md) | [2.7%](/filings/0000051143-25-000015.md) | [12.1%](/filings/0000051143-26-000010.md) | [9.6%](/filings/0000051143-26-000010.md) | [15.7%](/filings/0000051143-26-000010.md) |
| Diluted EPS | $ per share | [6.35](/filings/0000051143-24-000012.md) | [1.80](/filings/0000051143-25-000015.md) | [8.14](/filings/0000051143-26-000010.md) | [6.43](/filings/0000051143-26-000010.md) | [11.17](/filings/0000051143-26-000010.md) |
| Free cash flow | $bn | [10.7](/filings/0000051143-24-000012.md) | [9.1](/filings/0000051143-25-000015.md) | [12.7](/filings/0000051143-26-000010.md) | [12.4](/filings/0000051143-26-000010.md) | [12.1](/filings/0000051143-26-000010.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ibm/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $21.59bn | 76,763,481 |  | Reduced −802,472 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.26bn | 61,385,366 |  | Added +539,761 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $15.76bn | 56,045,055 |  | Added +1,450,562 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $7.97bn | 28,348,295 |  | Added +687,429 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.58bn | 23,448,500 |  | Added +372,171 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $4.91bn | 17,459,828 |  | Reduced −2,171,123 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $4.56bn | 16,207,905 |  | Reduced −854,548 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $4.21bn | 14,988,328 |  | Reduced −1,075,325 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $3.46bn | 12,445,411 |  | Reduced −6,099,283 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $2.88bn | 10,227,731 |  | Reduced −77,057 |

## Recent filings

[All 4,056 filings](/companies/ibm/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 22:15 ET | [10-Q](/filings/0000051143-26-000095.md) | Quarterly report, period 2026-09-30 | 0000051143-26-000095 |
| 2026-10-21 | 20:19 ET | [8-K](/filings/0000051143-26-000093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000051143-26-000093 |
| 2026-10-01 | 20:18 ET | [8-K](/filings/0000051143-26-000086.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000051143-26-000086 |
| 2026-08-14 | 20:05 ET | [8-K](/filings/0001104659-26-097089.md) | 9.01 Financial statements and exhibits | 0001104659-26-097089 |
| 2026-07-23 | 22:14 ET | [10-Q](/filings/0000051143-26-000078.md) | Quarterly report, period 2026-06-30 | 0000051143-26-000078 |
| 2026-07-22 | 20:10 ET | [8-K](/filings/0000051143-26-000077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000051143-26-000077 |
| 2026-07-14 | 11:01 ET | [8-K](/filings/0000051143-26-000070.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000051143-26-000070 |
| 2026-06-23 | 20:18 ET | [8-K](/filings/0000051143-26-000061.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000051143-26-000061 |
| 2026-05-28 | 10:49 ET | [8-K](/filings/0000051143-26-000047.md) | 7.01 Regulation FD disclosure | 0000051143-26-000047 |
| 2026-05-01 | 20:18 ET | [8-K](/filings/0000051143-26-000043.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0000051143-26-000043 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000051143-26-000010.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 51143
- Tickers: IBM
- Exchange: NYSE
- SIC code: 3570 Computer & office Equipment
- State of incorporation: NY
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.